Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish

Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):e104-16. doi: 10.1161/ATVBAHA.112.250035. Epub 2012 Jul 26.

Abstract

Objective: Endothelial sphingosine-1-phosphate (S1P) receptor-1 (S1P(1)) affects different vascular functions, including blood vessel maturation and permeability. Here, we characterized the role of the zS1P(1) ortholog in vascular development in zebrafish.

Methods and results: zS1P(1) is expressed in dorsal aorta and posterior cardinal vein of zebrafish embryos at 24 to 30 hours postfertilization. zS1P(1) downregulation by antisense morpholino oligonucleotide injection causes early pericardial edema, lack of blood circulation, alterations of posterior cardinal vein structure, and late generalized edema. Also, zS1P(1) morphants are characterized by downregulation of vascular endothelial cadherin (VE-cadherin) and Eph receptor EphB4a expression and by disorganization of zonula occludens 1 junctions in posterior cardinal vein endothelium, with no alterations of dorsal aorta endothelium. VE-cadherin knockdown results in similar vascular alterations, whereas VE-cadherin overexpression is sufficient to rescue venous vascular integrity defects and EphB4a downregulation in zS1P(1) morphants. Finally, S1P(1) small interfering RNA transfection and the S1P(1) antagonist (R)-3-amino-(3-hexylphenylamino)-4-oxobutylphosphonic acid (W146) cause EPHB4 receptor down-modulation in human umbilical vein endothelial cells and the assembly of zonula occludens 1 intercellular contacts is prevented by the EPHB4 antagonist TNYL-RAW peptide in these cells.

Conclusions: The data demonstrate a nonredundant role of zS1P(1) in the regulation of venous endothelial barrier in zebrafish and identify a S1P(1)/VE-cadherin/EphB4a genetic pathway that controls venous vascular integrity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anilides / pharmacology
  • Animals
  • Animals, Genetically Modified
  • Antigens, CD / metabolism
  • CHO Cells
  • Cadherins / metabolism
  • Capillary Permeability* / drug effects
  • Cricetinae
  • Cricetulus
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism*
  • Gene Expression Regulation, Developmental
  • Green Fluorescent Proteins / biosynthesis
  • Green Fluorescent Proteins / genetics
  • Human Umbilical Vein Endothelial Cells / drug effects
  • Human Umbilical Vein Endothelial Cells / metabolism
  • Humans
  • Membrane Proteins / metabolism
  • Morpholinos / metabolism
  • Oligonucleotides, Antisense / metabolism
  • Organophosphonates / pharmacology
  • Phosphoproteins / metabolism
  • RNA Interference
  • Receptor, EphB4 / metabolism
  • Receptors, Lysosphingolipid / antagonists & inhibitors
  • Receptors, Lysosphingolipid / genetics
  • Receptors, Lysosphingolipid / metabolism*
  • Sphingosine-1-Phosphate Receptors
  • Tight Junctions / metabolism
  • Transfection
  • Veins / drug effects
  • Veins / embryology
  • Veins / metabolism*
  • Zebrafish / embryology
  • Zebrafish / genetics
  • Zebrafish / metabolism*
  • Zebrafish Proteins / antagonists & inhibitors
  • Zebrafish Proteins / genetics
  • Zebrafish Proteins / metabolism*
  • Zonula Occludens-1 Protein

Substances

  • 3-amino-4-(3-hexylphenylamino)-4-oxobutylphosphonic acid
  • Anilides
  • Antigens, CD
  • Cadherins
  • Membrane Proteins
  • Morpholinos
  • Oligonucleotides, Antisense
  • Organophosphonates
  • Phosphoproteins
  • Receptors, Lysosphingolipid
  • S1PR1 protein, human
  • Sphingosine-1-Phosphate Receptors
  • TJP1 protein, human
  • Zebrafish Proteins
  • Zonula Occludens-1 Protein
  • cadherin 5
  • enhanced green fluorescent protein
  • Green Fluorescent Proteins
  • Receptor, EphB4